Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Gains from Investment Securities (2016 - 2025)

Neurocrine Biosciences' Gains from Investment Securities history spans 15 years, with the latest figure at -$3.4 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities changed N/A year-over-year to -$3.4 million; the TTM value through Dec 2025 reached $259.2 million, down 43.85%, while the annual FY2024 figure was $271.6 million, 35.26% up from the prior year.
  • Gains from Investment Securities reached -$3.4 million in Q3 2025 per NBIX's latest filing, down from $262.6 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $262.6 million in Q4 2024 to a low of -$3.4 million in Q3 2025.
  • Average Gains from Investment Securities over 4 years is $80.3 million, with a median of $10.8 million recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: tumbled 85.94% in 2021, then soared 31.96% in 2024.
  • A 4-year view of Gains from Investment Securities shows it stood at $1.8 million in 2021, then surged by 10955.56% to $199.0 million in 2023, then skyrocketed by 31.96% to $262.6 million in 2024, then plummeted by 101.29% to -$3.4 million in 2025.
  • Per Business Quant, the three most recent readings for NBIX's Gains from Investment Securities are -$3.4 million (Q3 2025), $262.6 million (Q4 2024), and $199.0 million (Q4 2023).